Cargando…

Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa

In this study, we examined the in vitro effect of tobramycin-efflux pump inhibitor (TOB-EPI) conjugates in combinations with fluoroquinolones, rifampicin and fosfomycin on the growth of multi-drug resistant (MDR) and extremely-drug resistant (XDR) Pseudomonas aeruginosa. The TOB-EPI conjugates inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xuan, Domalaon, Ronald, Lyu, Yinfeng, Zhanel, George G., Schweizer, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069439/ https://www.ncbi.nlm.nih.gov/pubmed/29932132 http://dx.doi.org/10.3390/jcm7070158

Ejemplares similares

Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria
por: Domalaon, Ronald, et al.
Publicado: (2019)

Spread of Efflux Pump Overexpressing-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa by using an Efflux Pump Inhibitor
por: Adabi, Maryam, et al.
Publicado: (2015)

Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa
por: Dhiman, Shiv, et al.
Publicado: (2023)

Detection of Overexpression of Efflux Pump Expression in Fluoroquinolone-Resistant Pseudomonas aeruginosa Isolates
por: Al Rashed, Nouf, et al.
Publicado: (2020)

Exploring Antibiotic-Potentiating Effects of Tobramycin–Deferiprone Conjugates in Pseudomonas aeruginosa
por: Gandhi, Karan, et al.
Publicado: (2023)

Dioctanoyl Ultrashort Tetrabasic β-Peptides Sensitize Multidrug-Resistant Gram-Negative Bacteria to Novobiocin and Rifampicin
por: Ramirez, Danyel, et al.
Publicado: (2021)

Collateral Sensitivity to Fosfomycin of Tobramycin-Resistant Mutants of Pseudomonas aeruginosa Is Contingent on Bacterial Genomic Background
por: Genova, Roberta, et al.
Publicado: (2023)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
por: Zhanel, George G., et al.
Publicado: (2018)

Evidence of MexT-Independent Overexpression of MexEF-OprN Multidrug Efflux Pump of Pseudomonas aeruginosa in Presence of Metabolic Stress
por: Kumar, Ayush, et al.
Publicado: (2011)

2813. Impact of a Recent Change in Tobramycin Breakpoints (CLSI) on the Proportion of Pseudomonas aeruginosa Clinical Isolates that are Multidrug-Resistant: CANWARD, 2016 to 2021
por: Walkty, Andrew, et al.
Publicado: (2023)

Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa
por: Siriyong, Thanyaluck, et al.
Publicado: (2017)

Biochemistry of Bacterial Multidrug Efflux Pumps
por: Kumar, Sanath, et al.
Publicado: (2012)

Microbial Primer: Multidrug efflux pumps
por: Siasat, Pauline Ann, et al.
Publicado: (2023)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

Multidrug Efflux Pumps in Staphylococcus aureus: an Update
por: Costa, Sofia Santos, et al.
Publicado: (2013)

RND multidrug efflux pumps: what are they good for?
por: Alvarez-Ortega, Carolina, et al.
Publicado: (2013)

Tripartite assembly of RND multidrug efflux pumps
por: Daury, Laetitia, et al.
Publicado: (2016)

Function and Inhibitory Mechanisms of Multidrug Efflux Pumps
por: Nishino, Kunihiko, et al.
Publicado: (2021)

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
por: MacLeod, David L., et al.
Publicado: (2009)

Biocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae
por: Slipski, Carmine J., et al.
Publicado: (2017)

Contribution of OqxAB Efflux Pump in Selection of Fluoroquinolone-Resistant Klebsiella pneumoniae
por: Szabo, Orsolya, et al.
Publicado: (2018)

A framework for dissecting affinities of multidrug efflux transporter AcrB to fluoroquinolones
por: Vergalli, Julia, et al.
Publicado: (2022)

Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region
por: Taneja, Neelam, et al.
Publicado: (2015)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
por: Zhanel, George G., et al.
Publicado: (2020)

Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon
por: Morita, Yuji, et al.
Publicado: (2015)

Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa
por: Lorusso, Andre Bittencourt, et al.
Publicado: (2022)

Identification of a multidrug efflux pump in Flavobacterium johnsoniae
por: Clark, Sarah E., et al.
Publicado: (2009)

Structural basis for the blockade of MATE multidrug efflux pumps
por: Radchenko, Martha, et al.
Publicado: (2015)

Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus
por: Mahey, Nisha, et al.
Publicado: (2021)

Role of the Multidrug Resistance Efflux Pump MexCD-OprJ in the Pseudomonas aeruginosa Quorum Sensing Response
por: Alcalde-Rico, Manuel, et al.
Publicado: (2018)

Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa
por: Sanz-García, Fernando, et al.
Publicado: (2022)

Drug resistance and physiological roles of RND multidrug efflux pumps in Salmonella enterica, Escherichia coli and Pseudomonas aeruginosa
por: Yamasaki, Seiji, et al.
Publicado: (2023)

The combined antimicrobial activity of citrus honey and fosfomycin on multidrug resistant Pseudomonas aeruginosa isolates
por: Abdelhady, Amira Saied M, et al.
Publicado: (2020)

MexXY multidrug efflux system of Pseudomonas aeruginosa
por: Morita, Yuji, et al.
Publicado: (2012)

MBLs, Rather Than Efflux Pumps, Led to Carbapenem Resistance in Fosfomycin and Aztreonam/Avibactam Resistant Elizabethkingia anophelis
por: Chang, Yanbin, et al.
Publicado: (2021)

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada
por: Zhanel, George G., et al.
Publicado: (2018)

Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.
por: Downs, J. T., et al.
Publicado: (1986)

Efflux pump regulatory genes mutations in multidrug resistance Pseudomonas aeruginosa isolated from wound infections in Isfahan hospitals
por: Vaez, Hamid, et al.
Publicado: (2014)

Interaction of antibacterial compounds with RND eﬄux pumps in Pseudomonas aeruginosa
por: Dreier, Jürg, et al.
Publicado: (2015)

Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence
por: Rampioni, Giordano, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cpndn3rvtjumnn600b265lct6h